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Mutations in the type VII collagen gene (COL7A1) cause autosomal recessive and autosomal dominant inherited
dystrophic epidermolysis bullosa (DEB). We report a family with three individuals who present blistering, scarring,
hypo- and hyperpigmentation, and nail dystrophy suggestive for DEB. Whereas father and son carry a 5;13 trans-
location, the daughter shows a normal karyotype. Segregation analysis revealed that all affected family members
inherited the same COL7A1 allele. Mutation analysis disclosed a heterozygous missense mutation, c.6227G4A
(p.G2076D), in COL7A1 in all affected individuals. Delineation of the translocation breakpoints showed that the
ERBB2IP (erbb2 interacting protein or Erbin) gene is disrupted in 5q13.1 and GPC6 in 13q32. GPC6 encodes
glypican 6 belonging to a family of cell surface heparan sulfate proteoglycans. The binding partners of Erbin,
BP230 (BPAG1) and the integrin b4 subunit, both involved in hemidesmosome (HD) function, and the presence of
Erbin in HD suggested that it plays a role in establishment and maintenance of cell-basement membrane adhesions.
However, loss of function of one ERBB2IP copy or expression of a putative novel ERBB2IP fusion protein did not
apparently modulate the DEB phenotype in both translocation patients. Nonetheless, one cannot yet exclude that
ERBB2IP is a candidate for human blistering disorders such as epidermolysis bullosa.
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Epidermolysis bullosa (EB) describes a group of clinically
and genetically heterogenous disorders characterized by
blistering of the skin and other epithelia. Patients with dys-
trophic EB (DEB) show mucocutaneous blistering, followed
by extensive scarring and nail dystrophy (Bruckner-Tuder-
man, 1999). Autosomal dominant (DDEB) or autosomal re-
cessive (RDEB) inheritance has been described for DEB;
however, each form has its specific clinical presentation and
severity. Both DDEB and RDEB are caused by mutations in
the same gene, COL7A1 in 3p21.1, encoding type VII col-
lagen, the major component of anchoring fibrils (Bruckner-
Tuderman, 1999). Although extensive clinical and molecular
heterogeneities exist in DEB, no evidence for additional loci
has yet been provided and all DEB variants seem to be
allelic. Indeed, both the Pasini and Cockayne–Touraine var-
iants of DEB have been shown to be caused by missense
mutations in COL7A1 (Kon et al, 1997). In general, the type
and combination of COL7A1 mutations may predict the
clinical severity and progression of the DEB phenotype
(Uitto and Richard, 2004).
Here we describe a family with three members affected
by DDEB and two, father and son, carrying a 5;13 trans-
location that disrupts the ERBB2IP gene in 5q13. ERBB2IP
encodes the basolateral protein Erbin that binds to the 230-
kDa bullous pemphigoid antigen (BP230/BPAG1) and the
integrin b4 subunit, suggesting that Erbin may be involved in
regulating the assembly of hemidesmosomes (HD).
Results and Discussion
In a five-generation extended family (Fig 1A), four individ-
uals (II-1, III-3, IV-2, and IV-5) in three generations were af-
fected by skin blistering. Based on the clinical phenotype
and the family history, an autosomal dominant DEB-type
Cockayne–Touraine was assumed to segregate in all af-
fected family members.
To identify the causative mutation in the affected per-
sons, we performed haplotype analysis using polymorphic
DNA markers closely linked to known EB loci. As no
immunohistological analyses of the patients’ skin were
available, we could not formally exclude the possibility that
the affected persons presented an EB subtype that differs
from DEB, such as e.g., EB simplex. Segregation analysis
excluded an involvement of the genes KRT5 and KRT14 in
the EB phenotype of the patients (data not shown). In con-
trast, haplotype analysis of the COL7A1-harboring allele
showed that the same disease allele is present in all affect-1Both authors contributed equally to this work.
Abbreviations: DEB, dystrophic epidermolysis bullosa; FISH, fluo-
rescent in situ hybridization; HD, hemidesmosome
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ed members (Fig 1B). Subsequently, we identified a het-
erozygous missense mutation in exon 75 of COL7A1,
c.6227G4A (p.G2076D), in the three affected individuals
(III-3, IV-2, and IV-5) (Fig 1C). This mutation has been pre-
viously reported to be associated with the Pasini type of
autosomal dominant DEB (Kon et al, 1997), indicating that
the COL7A1 mutation is causative for the disease pheno-
type in this family. Comparison of expected and observed
mutations in COL7A1 in DEB patients revealed that substi-
tution of any glycine by different amino acids will cause
disease, supporting the notion that this missense mutation
is indeed pathogenic (Persikov et al, 2004).
Remarkably, conventional cytogenetic analysis revealed
that both the affected father (III-3) and his son (IV-5) carry an
apparently balanced translocation between chromosomes
5 and 13, 46,XX,t(5;13)(q13;q32) (Fig 2A). The daughter (IV-
2), however, showed a normal karyotype, suggesting that
the translocation is not primarily associated with the dis-
ease phenotype in the family. Individuals II-2, IV-6, and IV-7
show a normal karyotype whereas individual IV-4 has not
been investigated. Taken together, these findings indicate
that the c.6227G4A mutation in COL7A1 is causative for
the skin disorder, although we cannot yet exclude that dis-
ruption of a gene(s) in the breakpoint region(s) may have a
modulating effect on the phenotype. Therefore, we deline-
ated the breakpoint regions of the 5;13 translocation by
fluorescence in situ hybridization (FISH), and breakpoint
spanning BAC clones were identified for both breakpoint
regions. For 5q13, BAC CTD-2033C11 showed split signals
on both derivative chromosomes 5 and 13 (Fig 2B), whereas
RP11-158B14 overlaps the 13q32 breakpoint (Fig 2C).
By database searches, we found that almost the entire
ERBB2IP (erbb2 interacting protein) gene is located on
the insert of CTD-2033C11, suggesting that the breakpoint
directly disrupts ERBB2IP (Fig 2D). The breakpoint span-
ning clone RP11-158B14 harbors exons 5 and 6 of the
GPC6 (glypican 6) gene that consists of nine exons in
total, indicating that this gene is interrupted by the trans-
location breakpoint in 13q32 (Fig 2D). Indeed, we confirmed
disruption of both genes by generating various ERBB2IP–
GPC6 fusion transcripts from RNA isolated from the
two translocation patients (data not shown) that were not
amplified from RNA of control persons. In the most
abundant fusion transcript, exons 1–7 of ERBB2IP were
spliced to GPC6 exons 6–8; however, no ERBB2IP–GPC6
fusion protein is generated from this transcript as the open
reading frame (ORF) of ERBB2IP exon 7 ends with the
second base of a triplet whereas the ORF of GPC6 exon
6 begins with the first nucleotide of a triplet. Thus, a putative
novel ERBB2IP protein could be produced consisting of
the N-terminal 178 amino acids of Erbin and 51 unrelated
amino acids encoded by a part of GPC6 exon 6 (Fig 2E).
Together, the data suggest that the translocation breakpoint
in 5q13 is located in intron 7 of ERBB2IP and in GPC6 intron
5 in 13q32.
GPC6 encodes a new member of the glypican family of
cell surface heparan sulfate proteoglycans (Paine-Saunders
et al, 1999; Veugelers et al, 1999). Glypicans play a role in
developmental morphogenesis, e.g., mutations in the X-
linked GPC3 gene cause the Simpson–Golabi–Behmel syn-
drome (SGBS), an overgrowth syndrome (Pilia et al, 1996).
Males typically affected by SGBS show tall stature, coarse
face, supernumerary nipples, congenital heart defect, and
generalized muscular hypotonia (Neri et al, 1998). The two
male patients affected by DEB do not show any symptoms
typical for SGBS.
Figure 1
Identification of a pathogenic missense mutation in COL7A1 in
three affected family members. (A) Pedigree of the five-generation
Bulgarian family. Individuals carrying the 5;13 translocation (t5;13) as
well as those with a normal karyotype (N) are indicated. The karyotype
of individual IV-4 is not known (?). (B) Partial pedigree of the family and
segregation analysis of COL7A1 alleles. The COL7A1 gene is located
between markers D3S2420 and D3S2384. All affected persons share
one allele (gray box) that was not inherited from the healthy grand-
mother. (C) A heterozygous p.G2076D missense mutation in COL7A1 in
the family members affected by DEB. Electrophortogram of a part of
COL7A1 exon 75. Direct sequencing of the exon 75 amplicon revealed
a heterozygous base change, c.6227G4A (indicated by a red arrow),
causing an amino acid change from glycine (Gly) to aspartic acid (Asp).
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ERBB2IP codes for a protein called Erbin, originally
identified as a binding partner of the ERBB2/HER2 receptor
(Borg et al, 2000). Erbin belongs to the LAP (leucine-rich
repeats and PDZ domains) protein family, critically involved
in establishing cell polarity (Santoni et al, 2002). Various
binding partners of Erbin have been identified, as e.g.,
p0071 (plakophilin-4), BP230 (BPAG1), and the b4 subunit
of integrins (Favre et al, 2001; Jaulin-Bastard et al, 2002).
p0071 is a protein linked to the cytoskeleton that colocal-
ized with Erbin in desmosomes of human colon cells (Jaulin-
Bastard et al, 2002). BP230 (230-kDa bullous pemphigoid
antigen/BPAG1) is a component of HD. These are special-
ized transmembrane cell–matrix junctions that mediate the
contact between basal keratinocytes and the basement
membrane. Additional HD components are the a6b4 inte-
grins and collagen XVII, also called the 180-kDa bullous
pemphigoid antigen or bullous pemphigoid antigen 2
(BP180/BPAG2/COL17A1), both transmembrane molecules
associated with HD that link the intermediate filament cyto-
skeleton to the extracellular matrix of the basement mem-
brane (Jonkman, 1999). HD are important for the integrity of
the dermal–epidermal junction, and any disturbance result-
ing in either the absence of one of the HD components or
causing altered protein–protein interactions can lead to au-
tosomal recessively inherited hemidesmosomal EB variants.
For example, mutations in ITGA6 and ITGB4, encoding
a6b4 integrin, have been identified in patients with junc-
tional EB with pyloric atresia (Vidal et al, 1995; Pulkkinen
et al, 1997). Moreover, mutations in the BPAG2-encoding
gene COL17A1 were found in patients with generalized
atrophic benign EB (McGrath et al, 1995). Consequently, the
presence of Erbin in desmosomes and HD suggested that it
may play a role in the establishment and maintenance of
cell–cell and cell–basement membrane adhesions. This hy-
pothesis is supported by the finding that mice deficient for
the scaffold protein GRIP1, which contains seven PDZ do-
mains, show extensive skin blistering reminiscent of DEB
(Bladt et al, 2002). Although no disease-causing mutations
have yet been found in BPAG1, ERBB2IP, or GRIP1, it is
tempting to speculate that these genes are obvious candi-
dates for human blistering skin disorders such as EB. Con-
sequently, we assumed that disruption of ERBB2IP in both
father (III-3) and son (IV-5) with DEB may modulate their
phenotype. Therefore, we compared the phenotype of in-
Figure2
The translocation disrupts ERBB2IP in 5q13 and GPC6 in 13q32. (A)
Schematic representation of the 5;13 translocation. The ideograms of
the normal and derivative (der) chromosomes 5 and 13 are shown. The
breakpoints at 5q13 and 13q32 are indicated by wavy lines. (B and C)
Identification of overlapping BAC clones for the breakpoint regions in
5q13 and 13q32 by fluorescence in situ hybridization (FISH). (B) FISH
with BAC clone CTD-2033C11 hybridized to lymphocyte metaphase
spreads of patient IV-5. The probe is labeled by fluorescein is-
othiocyanate (green). BAC CTD-2033C11 shows signals on wild-type
chromosome 5, der(5), and der(13). (C) FISH with BAC clone RP11-
158B14 on lymphocyte metaphase spreads of individual IV-5 that
produces a signal (green) on wild-type chromosome 13 and on both
derivative chromosomes [der(5) and der(13)]. Chromosomes are
counterstained with diamidinophenyl indole. (D) Schematic represen-
tation of the breakpoint regions in 5q13 (left) and 13q32 (right). Chro-
mosomal parts of 5q13 and 13q32, respectively, are shown
schematically. BAC clones used for FISH are indicated by colored
bars: BACs hybridizing proximal to the breakpoint are indicated in blue,
those hybridizing distal are shown in green, and breakpoint spanning
clones are shown in red. Names of BACs are given. Exons of ERBB2IP
and GPC6 are represented by black bars and are partially numbered on
the left. Breakpoints are indicated by wavy lines. (E) Schematic rep-
resentation of an ERBB2IP–GPC6 fusion transcript identified in the
translocation patients. Exons are indicated by boxes and numbered;
white boxes represent various ERBB2IP exons whereas red boxes
represent those of the GPC6 gene. The ATG start codon of ERBB2IP
in exon 3 is indicated. ERBB2IP amino acids (single letter code) up to
the end of exon 7 are shown in black: amino acid residues encoded
by GPC6 from exon 6 onward are shown in red. The residues of the
novel 51 amino acid peptide resulting from the translocation (encoded
by GPC6 exon 6 but in a different open reading frame) are shown
in orange.
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dividuals III-3 and IV-5 with that of IV-2 showing a normal
karyotype.
Patient III-3 (58 y old; height: 168 cm), the father of pa-
tients IV-2 and IV-5, presented skin lesions affecting pre-
dominantly the hands and knees as well as the pretibial
regions (Fig 3A and F). Blisters healed with scarring, skin
atrophy, and hypo- and hyperpigmentation (Fig 3F). His toe
nails showed dystrophy and some of them were completely
lost whereas all fingernails were lost (Fig 3A). The daughter
from the first marriage of individual III-3 (IV-2) is 31 y old.
She has been initially seen by one of us (M. S.) at the age of
17. Soon after birth she developed painful bullous skin le-
sions, mainly on distal parts of arms and legs as well as
elbows and knees (Fig 3B and G). The lesions were caused
even by mild injuries and healed very slowly with scars; her
nails were dystrophic or lost (Fig 3B and D). There was no
other organ involvement. The 9-y-old son of patient III-3 (IV-
5) was referred to the Clinical Genetics Unit because of skin
blistering starting at day 2 postnatal. He was born to a
healthy mother of caucasian origin (III-4), after Cesarean
section because of fetal cardiac decelerations at 39 wk of
gestation. Birth weight and length were normal. Bullous skin
lesions occurred spontaneously; they had a serous or hem-
orrhagic content. There was evidence, however, for blister-
ing exacerbation after mechanical trauma. All blisters were
localized over the dorsal part of the hands and feet and on
the lower legs (Fig 3C and H), whereas other regions as well
as the trunk, limbs, eyes, and the oral mucosa were unaf-
fected. Long-term follow-up of patient IV-5 showed a nor-
mal mental and physical development (height: 120 cm at the
age of 7.5 y). He underwent treatment either systemic with
vitamin E or/and topical with emollients and corticosteroids
without any significant clinical improvement. Until the age of
4.5 y, there was a slow expansion and progression of the
lesions; nails became dystrophic (Fig 3E) and skin scars and
areas of hypo- and hyperpigmentation developed on the
distal parts of the limbs (Fig 3H) similar to those observed in
the father. Anamnestically, the deceased father of individual
III-3 (II-1) had similar skin lesions. Patient III-3 as well as his
son (IV-5) neither have oral problems nor anemia. Taken
together, the clinical phenotypes of the three affected per-
sons are very similar, showing no significant differences that
might be associated with different karyotypes. But both fa-
ther (III-3) and son (IV-5) carrying the 5;13 translocation
show a mild facial dysmorphism, e.g., hypoplasia of the
maxilla (Fig 3I–L).
In light of the skin disease segregating in the family de-
scribed here, interruption of ERBB2IP, encoding a protein
possibly implicated in HD function, is challenging. None-
theless, the COL7A1 missense mutation p.G2076D is most
likely associated with DEB in the affected members of the
family described here. Moreover, loss of function of one
ERBB2IP copy or, alternatively, expression of a putative
novel ERBB2IP fusion protein that might act in a dominant-
negative manner does not seem to modulate the EB phe-
notype in father and son. One cannot, however, exclude
that disruption of ERBB2IP as well as missense, nonsense,
or splice mutations in this gene are implicated in EB.
Materials and Methods
Patients A five-generation Bulgarian family (Fig 1A) with three in-
dividuals (III-3, IV-2, and IV-5) in two generations who were affected
by skin blistering as well as four unaffected individuals (II-2, III-4,
IV-6, and IV-7) were included in this study. Peripheral blood sam-
ples were taken from patients for DNA isolation and chromosome
preparations in adherence to the Declaration of Helsinki Guide-
lines, following their informed consent and the relevant ethics
committee approval for this study.
Microsatellite typing PCR amplification for the analysis of micro-
satellite markers was performed on genomic DNA from individuals
II-2, III-3, III-4, IV-2, and IV-5. Genomic DNA was isolated by
standard procedures. Haplotype analysis of the KRT14 allele was
carried out with D17S846, D17S1563, and D17S967, with
D12S297, D12S368, D12S390, and D12S766 for the KRT5 allele,
and with D3S3640, D3S3729, D3S2420, and D3S2384 for the
COL7A1 allele. Primer sequences and PCR conditions are avail-
able on request. Amplification products were electrophoresed on
8% polyacrylamide gels at 400 V for  2 h. Subsequently, bands
were detected by silver staining.
Mutation analysis of COL7A1 Mutation detection was performed
by direct sequencing of the coding region of the COL7A1 gene. For
amplification of all 118 COL7A1 exons and exon/intron boundaries,
73 pairs of primers were designed according to Christiano et al
(1997) with modifications. For exons 73–75 the following PCR
Figure 3
Representative photographs of the family members affected by
dystrophic epidermolysis bullosa. Hand of individual III-3 (A), that of
the daughter of III-3 (IV-2) (B), and one hand of the 9-y-old son of
patient III-3 (IV-5) (C). Toenails of patients IV-2 (D) and IV-5 (E). Pretibial
region of individual III-3 (F), his daughter (G), and son (H). Facial ap-
pearance of patient III-3 (I and J) and his son (IV-5) (K and L). Note
hypoplasia of the maxilla in both individuals. For detailed description of
the photos, see text.
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primers were used: 50-CCACCAGCATTCTCTCTTCCA-30 and 50-
TGGCTTCCTGGTCACTAGTCA-30 generating a product of 556 bp;
sequencing primers were 50-AGCCTGGAAAGCCTGGTATT-30, and
50-ACAGGACTAAGGCAGGGATG-30. PCR products were directly
sequenced with the internal primers listed above using the BigDye
Terminator Kit 1.1 (Applied Biosystems, Darmstadt, Germany).
Samples were analyzed on an ABI 3100 automated sequencer
(Applied Biosystems).
Conventional cytogenetic and FISH studies Chromosome prep-
arations were made from phytohemagglutinin-stimulated periph-
eral blood lymphocytes. Conventional cytogenetic analysis of G-
banded chromosomes was carried out by high-resolution banding
(500-band level). FISH was performed as previously described
(Kutsche et al, 2000). Briefly, BAC DNA were labeled with biotin-16-
dUTP by nick translation (Roche, Mannheim, Germany). Fluo-
rescein isothiocyanate-labeled streptavidin (1:200) was used for
detection. Chromosomes were counterstained using diamidino-
phenyl indole (Roche) and mounted in antifading solution (Vector
Labs, Burlingame, California). Slides were analyzed with a Leica
Axioscope fluorescence microscope. Images were merged using a
cooled CCD camera (Pieper, Schwerte, Germany) and Cyto Vision
(Applied Imaging, San Jose, California) software.
BAC clones BAC clones RP11-342E2, RP11-145B14, RP11-
210E23, and RP11-480H11 were provided by the Resource Cen-
ter of the German Human Genome Project at the Max-Planck-
Institute for Molecular Genetics, Berlin, Germany whereas BAC
clones CTD-2033C11 and CTD-2019M3 were obtained from In-
vitrogen (Karlsruhe, Germany). BAC DNA were prepared using a
Midiprep kit (Qiagen, Hilden, Germany).
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